Login / Signup

Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma.

Miltiadis E KrokidisDanae FakitsaKaterina MalagariTheodoros KarampelasDemosthenes FokasConstantin TamvakopoulosAchilles Chatziioannou
Published in: Cardiovascular and interventional radiology (2024)
Doxorubicin may be combined with antiangiogenic drugs with satisfactory in vitro loading and release outcomes and effect on cellular lines.
Keyphrases
  • drug delivery
  • cancer therapy
  • metabolic syndrome
  • skeletal muscle